Advertisement for orthosearch.org.uk
Results 1 - 10 of 10
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_10 | Pages 15 - 15
1 Feb 2013
Gill SL Hussain S MacLeod J Finlayson DF
Full Access

Revision hip surgery is reportedly rising inexorably yet not all units report this phenomenon. The outcome of 1143 consecutive Corin TaperFit primary hip arthroplasties (957 patients) performed between 1995 and 2010 is presented. The implants were cemented under pressurisation and combined the TaperFit stem with Ogee flanged cups. Data was gathered from local arthroplasty database and case note review of revised joints. 13 hips have been revised (1.1%). Cumulative prosthesis survival is 0.99 +/− 0.0. Two femoral stems were revised (0.2%); one at 6 months for sepsis, one at 14 days after dislodgment during reduction of dislocation. No revisions were undertaken for aseptic loosening of the stem or cup, nor for thigh pain. 32 patients (32 hips) ≥15 year follow up, 13 survive today and none have been revised (0%). Of the 471 with ≥10 year follow up, 38 were aged ≤50 at time of surgery and 1/38 has been revised to date (PLAD for dislocation). The strong population stability in this region, supported by independent investigation by Scottish Arthroplasty Project, endorses the accuracy of the data quoted. The low incidence of revision in this cohort, and absence of revision for aseptic loosening (mean follow up 8.03 years +/− SD 3.94; range 18 months to 16yrs 2 months), substantially supports the longevity and use of cemented, double-taper, polished, collarless femoral stems in combination with cemented polyethylene cups in primary hip arthroplasty in all patient age groups


Orthopaedic Proceedings
Vol. 96-B, Issue SUPP_12 | Pages 86 - 86
1 Jul 2014
Cameron H
Full Access

Modular necks arrived in North America in the late 1970s. The purpose was to allow ceramic balls to be attached to metal stems. The advantages of modularity were so obvious that it was universally adopted with almost no untoward consequences. A double-taper neck was developed in Italy by the Cremascoli Company and was used extensively with few reports of problems. Recently, problems have been reported not only with double-taper necks, but also with head-neck junction tapers. Something would appear to have changed recently. Some of these changes were shortening of the taper, lengthening of the neck, version angles were increased, and head sizes bigger than 32mm were introduced. Surface finish on some of the tapers was changed and they were ridged. This produces a better fit for a ceramic ball, but facilitates crevice corrosion with a metal ball. The author used the original OTI cemented stem with a double-taper neck between 2002 and 2005. It was a cobalt chrome construct. The Cremascoli was a titanium hip. The OTI used the classic Morse taper with cogs for increased rotational resistance. One hundred forty five stems were inserted. The neck stem taper broke in two cases and dislocated in one. All of these cases had a long neck and long heads and thus produced maximum moment arm. The stem was withdrawn from the market, the taper lengthened and the strength doubled. It was reintroduced in 2007. From 2007 to 2011, the author has done 188 cases, all cemented stems. No taper problems have occurred. The conclusion is that a properly designed double taper neck does not appear to have a downside. The upside is the ability to change neck length and especially version after head insertion. Leg length and hip centering can, therefore, be fine-tuned as never before. The author continues to use this stem enthusiastically for all cemented cases


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 509 - 509
1 Sep 2012
Thomas G Hossain M Monk A Gill H Glyn-Jones S Andrew J Murray D Beard D Epos Group N
Full Access

Introduction. Malalignment of some designs of stem is associated with an increased risk of aseptic loosening and revision. We investigated whether the alignment of the cemented polished, double-taper design adversely affected outcome, in a multicentre prospective study. Methods. A multicentre prospective study of 1189 total hip replacements was undertaken to investigate whether there is an association between surgical outcome and femoral stem alignment. All patients underwent a primary THR with the Exeter femoral stem (Stryker Howmedica Osteonics, Mahwah, NJ) and a variety of acetabular components. The primary outcome measure was the Oxford hip score (OHS) and change in OHS at five years. Secondary outcomes included rate of dislocation and revision. Radiographic evaluation of the femoral component was also undertaken. The long axis of the Exeter femoral component and the long axis of the femoral canal were located, and the angle at the point of intersection measured. The cementing quality was determined as defined by Barrack et al. Radiolucent lines at the cement-stem and cement-bone interface in the five year radiographs were defined using the zones described by Gruen et al. Subsidence was measured as the vertical dimension of the radiolucency craniolateral to the shoulder of the stem in Gruen zone 1 as described by Fowler et al. Cement fractures were recorded. Results. The incidence of varus (>5 ° to the femoral axis), and valgus (>5 °) malignment were 3.7% and 0.8% respectively. Pre-operative demographics and OHS were similar in all groups (p > 0.4). There was no significant difference in OHS or change in OHS between neutral and malaligned groups at 5 years (neutral, mean=40.1, change=23.1; varus, mean=40.1, change=23.7; valgus, mean=42.0, change=26.6; p=0.46 and p=0.45 respectively). There was no significant difference in dislocation rate between the groups (p=0.66). There was also no significant difference in revision rate (p=0.34). There were no statistically significant differences in the incidence of femoral radiolucency, stem subsidence or cement fracture (p > 0.1). Conclusion. This study provides evidence that both varus and valgus implantation does not compromise the short to medium term clinical results of the cemented, polished, double-taper stems. Longer follow-up is required to establish the influence of stem alignment on the incidence of aseptic loosening and revision


Orthopaedic Proceedings
Vol. 90-B, Issue SUPP_I | Pages 12 - 12
1 Mar 2008
Lamberton TD Charity J Kenny P Timperley AJ Gie G
Full Access

Impaction bone grafting with a cemented polished double-taper stem as a technique for revision of the femoral component was introduced in 1987 at our institution. As at January 2000, 540 cases in 487 patients had been performed. All procedures have been studied prospectively and there are no patients lost to follow-up. We present the survivorship and outcome data for these patients. Survivorship at 15 years is 90.6 percent [95 percent confidence interval: 88–93 percent]. Clinical scores show marked and sustained improvement. There have been 45 failures [8.3 percent]. Technical error contributed to 13 of the 24 non-infective complications, but with improved technique plus the addition of long stemmed impaction grafting, there have been no technical errors since 1996. Our results show that revision of the femoral component with impaction bone grafting is a reliable and durable technique with an acceptably low complication rate and with excellent survivorship at 15 years


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_I | Pages 28 - 29
1 Mar 2005
Lamberton T Charity J Kenny P Timperley A Gie G
Full Access

Impaction bone grafting in conjunction with a cemented polished double-taper stem as a technique for revision of the femoral component was introduced in 1987 at our institution. As at January 2000, 540 cases in 487 patients had been performed by multiple surgeons. All procedures have been studied prospectively, and there are no patients lost to follow-up. We present the survivorship and outcome data for these patients. Survivorship at 15 years is 90.6 percent (95 percent confidence interval:88–93 percent). Four hundred and six hips in 365 patients remain under active follow up, with 122 patients (134 hips) deceased. Averaged clinical scores taken preoperatively, 2 years postoperatively and at latest follow up showed marked and sustained improvement: Charnley Pain 2.7, 5.5, 5.3; Charnley Function 2.1, 4.1, 3.6; Charnley Range of Motion 4.0, 5.4, 5.3; Harris Pain 19, 38, 36; Harris Function 18, 32, 28; and Oxford Hip Score 41, 22, 25. There have been 45 failures (8.3 percent) at an average 7.6 year follow up (range 2.6–15.3 years). Technical error contributed to 13 of the 24 non-infective complications, but with improved technique plus the addition of long stemmed impaction grafting, there have been no technical errors since 1996. Our results show that revision of the femoral component with impaction bone grafting is a reliable and durable technique with an acceptably low complication rate with excellent survivorship at 15 years


Orthopaedic Proceedings
Vol. 88-B, Issue SUPP_I | Pages 68 - 68
1 Mar 2006
Lamberton T Charity J Kenny P Timperley A Gie G
Full Access

Introduction: Impaction bone grafting in conjunction with a cemented polished double-taper stem as a technique for revision of the femoral component was introduced in 1987 at our institution. Methods: As at January 2000, 540 cases in 487 patients had been performed by multiple surgeons. All procedures have been studied prospectively, and there are no patients lost to follow-up. We present the survivorship and outcome data for these patients. Results: Survivorship at 15 years is 90.6 percent (95 percent confidence interval: 88–93 percent). 406 hips in 365 patients remain under active follow up, with 122 patients (134 hips) deceased. Averaged clinical scores taken pre-operatively, 2 years post-operatively, and at latest follow-up show marked and sustained improvement: Charnley Pain 2.7, 5.5, 5.3; Charnley Function 2.1, 4.1, 3.6; Charnley Range of Motion 4.0, 5.4, 5.3; Harris Pain 19, 38, 36; Harris Function 18, 32, 28; and Oxford Hip Score 41, 22, 25. There have been 45 failures (8.3 percent) at an average 7.6 year follow up (range 2.6 – 15.3 years). Technical error contributed to 13 of the 24 non-infective complications, but with improved technique plus the addition of long stemmed impaction grafting, there have been no technical errors since 1996. Conclusion: Our results show that revision of the femoral component with impaction bone grafting is a reliable and durable technique with an acceptably low complication rate with excellent survivorship at 15 years


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_III | Pages 357 - 357
1 Sep 2005
Lamberton T Charity J Kenny P Timperley A Gie G
Full Access

Introduction and Aims: Impaction bone grafting in conjunction with a cemented polished double-taper stem as a technique for revision of the femoral component was introduced in 1987 at our institution. The aim of this study is to report on the outcome, survivorship, complications and radiological analysis of the first consecutive 540 cases performed in Exeter. Method: As at January 2000, 540 cases in 487 patients had been performed by multiple surgeons. All procedures have been studied prospectively, and there are no patients lost to follow-up. We present the survivorship and outcome data for these patients. Radiological analysis of the pre-operative, immediate post-operative and most recent follow-up radiographs was also performed. This included evaluation of the cement mantle and impacted allograft, stem subsidence within the cement mantle, presence of cortical healing and graft trabeculation on the follow-up radiographs, as well as appearance of radiolucencies and graft resorption. Results: Survivorship at 15 years is 90.6 percent (95 percent confidence interval: 88–93 percent). Four hundred and six hips in 365 patients remain under active follow-up, with 122 patients (134 hips) deceased. Averaged clinical scores taken pre-operatively, two years post-operatively, and at latest follow-up, show marked and sustained improvement: Charnley Pain 2.7, 5.5, 5.3; Charnley Function 2.1, 4.1, 3.6; Charnley Range of Motion 4.0, 5.4, 5.3; Harris Pain 19, 38, 36; Harris Function 18, 32, 28; and Oxford Hip Score 41, 22, 25. There have been 45 failures (8.3 percent) at an average 7.6-year follow-up (range 2.6–15.3 years). Technical error contributed to 13 of the 24 non-infective complications, but with improved technique plus the addition of long stemmed impaction grafting, there have been no technical errors since 1996. Conclusion: Our results show that revision of the femoral component with impaction bone grafting is a reliable and durable technique with an acceptably low complication rate with excellent survivorship at 15 years


Orthopaedic Proceedings
Vol. 88-B, Issue SUPP_II | Pages 244 - 244
1 May 2006
Lankester Spencer R Lee M Curwen C Blom M Ottesen T Learmonth I
Full Access

Introduction The CPS-Plus stem (Endoplus UK) is a polished double-taper with rectangular cross section maintained throughout for rotational stability. There are 5 stem sizes with proportionate offset, and 5 neck length options. A unique proximal stem centraliser has been shown to increase proximal cement pressurisation during insertion in-vitro, also assists with alignment of the stem and helps create an even cement mantle. RSA analysis has demonstrated linear subsidence in a vertical plane, without posterior head migration and valgus tilt. We report a multi-centre prospective clinical trial. 231 hips in 223 patients have been entered into the study. 151 of these have reached 3 years follow-up. Method Patients were recruited by surgeons working at three centres in the UK, and two in Norway. Merle d Aubigne and Postel, Harris, and Oxford hip scores were recorded pre-operatively and at follow-up (3, 6, 12, 24, 36, 60 months). Radiographic assessment included evaluation of subsidence and the presence of any radiolucencies. Results Hip scores have been very satisfactory. Radiological subsidence is less than 1.5mm in over 95% of cases and only one stem has subsided more than 3mm. There has been one revision for deep sepsis, 7 dislocations and one femoral fracture, but none of these complications were related to the choice of femoral component. There have been no revisions for aseptic loosening. Kaplan Meier survivorship analysis at 36 months for aseptic stem loosening is 0.997 (95% CI 0.977 – 1) and for all-cause revision is 0.981 (95% CI 0.958 – 1). 53 hips had reached 5-year follow-up at 30/9/04. Discussion The tradition of polished tapered stems arose from serendipity and most results have been excellent. The CPS-Plus stem represents an attempt to re-examine the issues relating to rotational stability, subsidence, cement pressurisation and offset. Earlier laboratory studies have now been supplemented by this clinical evaluation, performed in a number of different centres by several surgeons, and the evidence is encouraging. In particular, the RSA subsidence characteristics, cement pressurisation and rotational stability already associated with this implant in-vitro have been supported by excellent survivorship analysis, and the authors believe that increasing familiarity with the concepts raised by this implant will result in clinical benefits in relation to polished taper cemented stem longevity


Orthopaedic Proceedings
Vol. 88-B, Issue SUPP_I | Pages 73 - 73
1 Mar 2006
Learmonth I Lankester B Spencer R Learmonth I
Full Access

Introduction: The CPS-Plus stem (Endoplus UK) is a polished double-taper with a rectangular cross section maintained throughout for rotational stability. There are 5 stem sizes with proportionate offset, together with 5 neck length options, and a unique proximal stem centraliser which has been shown to increase proximal cement pressurisation during insertion in-vitro, assists with alignment of the stem and helps create an even cement mantle. RSA analysis has demonstrated linear subsidence in a vertical plane, without the posterior head migration and valgus tilt associated with other designs. Data on the CPS-Plus stem has been obtained from a multi-centre prospective clinical trial. 231 hips in 223 patients have been entered into the study. 151 of these have reached 3 years follow-up. Method: Patients were recruited by surgeons working at three centres in the UK and two in Norway. Merle d Aubigne and Postel, Harris, and Oxford hip scores were recorded pre-operatively and at follow-up (3, 6, 12, 24, 36, 60 months). Radiographic assessment included evaluation of subsidence and the presence of any radiolucencies. Results: Objective and subjective scoring have indicated very satisfactory results. Radiological subsidence is less than 1.5mm in over 95% of cases and only one stem has subsided more than 3mm. There has been one revision for deep sepsis, 7 dislocations and one femoral fracture, but none of these complications were related to the choice of femoral component. There have been no revisions for aseptic loosening. Kaplan Meier survivorship analysis at 36 months for aseptic stem loosening is 0.997 (95% CI 0.977 – 1) and for all-cause revision is 0.981 (95% CI 0.958 – 1). Discussion: The tradition of polished tapered stems arose from serendipity and most results have been excellent. The CPS-Plus stem represents an attempt to re-examine the issues relating to rotational stability, subsidence, cement pressurisation and offset. Earlier laboratory studies have now been supplemented by this clinical evaluation, performed in a number of different centres by several surgeons, and the evidence is encouraging. In particular, the RSA subsidence characteristics, cement pressurisation and rotational stability already associated with this implant in-vitro have been supported by excellent survivorship analysis, and the authors believe that increasing familiarity with the concepts raised by this implant will result in clinical benefits in relation to polished taper cemented stem longevity


Orthopaedic Proceedings
Vol. 86-B, Issue SUPP_I | Pages 76 - 76
1 Jan 2004
Lankester BJA Spencer RF Learmonth ID
Full Access

Introduction: The CPS-Plus cemented, collarless, polished stem, is a double-taper design with rectangular cross section. An additional proximal stem centraliser ensures optimal alignment of the stem and an even cement mantle and has been shown to increase cement pressurisation during insertion. Guidelines from the National Institute of Clinical Excellence (NICE) recommend comparative clinical evaluation for prostheses without long-term follow-up data and set an initial ‘benchmark’ for performance at 3 years. Data collection for the CPS-Plus stem is on-going as part of a multi-centre prospective clinical trial. 227 patients have been recruited to the trial and 70 of these have reached 3 years follow-up. Method: Patients were recruited to the study by surgeons working at three centres in the UK and two in Norway. Patients were fully evaluated pre-operatively. Operative details, post-operative course and follow-up visits at 3, 6, 12, 24, and 36 months were recorded. Postoperative clinical progress was monitored using recognised scoring systems and radiographic assessment. Results: The mean Harris hip score (0 – 100) improved from 42.7 pre-op to 91.6 at 6 months and 95.8 at 3 years. The mean Merle d’Aubigne and Postel score (0 – 18) improved from 8.55 pre-op to 16.09 at 6 months and 17.08 at 3 years. The mean Oxford hip score (60 – 12) improved from 41.6 pre-op to 14.1 at 3 years. Radiological subsidence at 3 years is less that 1.5mm in 97% of patients and less than 3mm in the remainder. From all 227 implants, there has been one revision for deep infection. There have been no cases of aseptic loosening. Other significant complications include one peri-prosthetic fracture and 4 dislocations, but these were not thought to be related to the design of the implant. Discussion: The early results of the CPS-Plus femoral stem are encouraging and the prosthesis achieves the 3-year benchmark set out in the NICE guidelines, with a zero revision rate in the first 70 patients recruited to the trial. The prosthesis shares many design features with other well-established collarless, polished, tapered stems. The ease of accurate insertion and improved cement pressurisation resulting from its unique design features should ensure excellent medium to long-term outcome. The multi-centre clinical trial will continue to monitor progress